U.S. health advisers endorsed a booster of Johnson & Johnson's COVID-19 vaccine Friday, citing growing worry that Americans who got the single-dose shot aren't as protected as those given two-dose brands.
Advisers to the Food and Drug Administration weighed J&J's proposal for a flexible booster schedule. The company said the extra dose adds important protection as early as two months after initial vaccination -- but that it might work better if people wait until six months later.
The FDA's advisory panel voted unanimously that a booster should be offered without setting a firm time. The advisers cited growing evidence that J&J recipients are more vulnerable to infection than people who got vaccines from competitors Pfizer or Moderna- and that most got their single dose many months ago.
Read More: [ Ссылка ]
Check out more Eyewitness News - [ Ссылка ]...
NEW HERE? –
Hi! We’re abc7NY, also known as Channel 7 on TV, home to Eyewitness News, New York’s Number 1 news. We hope you love us on YouTube as much as you do on television!
OUR SOCIAL MEDIA –
FACEBOOK: [ Ссылка ]... TWITTER: [ Ссылка ]... INSTAGRAM: [ Ссылка ]...
NEW TIPS:
Online: [ Ссылка ]...
Phone: 917-260-7700 Email: abc7ny@abc.com
#fda #johnson&johnson #covidvaccines
